<?xml version="1.0" encoding="UTF-8"?>
<p>Same as SARS-CoV and HCoV-NL63, SARS-CoV-2 uses host receptor ACE2 for the cellular entrance 
 <xref rid="B63" ref-type="bibr">63</xref>-
 <xref rid="B66" ref-type="bibr">66</xref>. Therefore, TCM with the capacity to target ACE2 holds the promise to prevent the infection of SARS-CoV-2. Emodin from genus 
 <italic>Rheum</italic> and 
 <italic>Polygonum</italic>
 <xref rid="B67" ref-type="bibr">67</xref>, baicalin from in 
 <italic>Scutellaria baicalensis</italic>
 <xref rid="B44" ref-type="bibr">44</xref>, 
 <xref rid="B68" ref-type="bibr">68</xref>, nicotianamine from foodstuff (especially “soybean ACE2 inhibitor (ACE2iSB)”) 
 <xref rid="B69" ref-type="bibr">69</xref>, scutellarin 
 <xref rid="B70" ref-type="bibr">70</xref>, tetra-
 <italic>O</italic>-galloyl-β-D-glucose (TGG) from 
 <italic>Galla chinensis</italic> and luteolin from 
 <italic>Veronicalina riifolia</italic>
 <xref rid="B71" ref-type="bibr">71</xref> markedly inhibited the interaction of SARS-CoV S-protein and ACE2. However, the anti-SARS-CoV activity of these compounds remain to be evaluated. In addition, inhibition of the 3a ion channel by emodin 
 <xref rid="B72" ref-type="bibr">72</xref> or kaempferol derivatives- juglanin 
 <xref rid="B73" ref-type="bibr">73</xref> could potentially prevent the viral release from the infected cells. Saikosaponins 
 <xref rid="B74" ref-type="bibr">74</xref>, glycyrrhizin 
 <xref rid="B48" ref-type="bibr">48</xref>, 
 <xref rid="B75" ref-type="bibr">75</xref>, quercetin and TSL-1 extracted from 
 <italic>Toona sinensis</italic> Roem 
 <xref rid="B76" ref-type="bibr">76</xref> purportedly had potent anti-SARS-CoV effects by inhibition of viral cellular entry, adsorption, and penetration.
</p>
